Keri Tate

2.3k total citations · 1 hit paper
19 papers, 1.7k citations indexed

About

Keri Tate is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Keri Tate has authored 19 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Hematology and 5 papers in Oncology. Recurrent topics in Keri Tate's work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Keri Tate is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (7 papers) and Hematopoietic Stem Cell Transplantation (5 papers). Keri Tate collaborates with scholars based in United States, Australia and France. Keri Tate's co-authors include Laurent J. Emorine, A. Donny Strosberg, Stéfano Marullo, Gilles Patey, Colette Delavier-Klutchko, Craig Beeson, Harden M. McConnell, Joshua D. Rabinowitz, Gordon A. Vehar and Christoph Wülfing and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

Keri Tate

18 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Characterization of the Human β ₃ -Adrenergic Receptor

1989 897 citations Laurent J. Emorine, Stéfano Marullo et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keri Tate United States	13	676	462	435	253	249	19	1.7k
Fu‐Zon Chung United States	20	897 1.3×	208 0.5×	201 0.5×	521 2.1×	86 0.3×	38	1.5k
John L. Trotter United States	32	804 1.2×	370 0.8×	1.5k 3.6×	379 1.5×	59 0.2×	67	3.5k
G. Drapeau Canada	25	1.0k 1.5×	280 0.6×	168 0.4×	1.0k 4.1×	39 0.2×	56	2.0k
Jean‐Luc Parent Canada	29	1.8k 2.6×	253 0.5×	285 0.7×	604 2.4×	26 0.1×	65	2.4k
Shun‐ichiro Matsumoto Japan	18	1.1k 1.6×	361 0.8×	673 1.5×	316 1.2×	20 0.1×	23	2.3k
David O. Willenborg Australia	32	668 1.0×	323 0.7×	1.9k 4.3×	159 0.6×	30 0.1×	77	3.2k
Kay Barnes United Kingdom	25	1.0k 1.5×	602 1.3×	235 0.5×	185 0.7×	11 0.0×	36	2.0k
Stephen R. Jaspers United States	16	1.1k 1.7×	265 0.6×	243 0.6×	150 0.6×	25 0.1×	36	2.0k
Martha H. Corjay United States	18	1.1k 1.6×	126 0.3×	155 0.4×	732 2.9×	25 0.1×	24	2.0k
Masao Katoh Japan	20	564 0.8×	262 0.6×	120 0.3×	111 0.4×	16 0.1×	36	1.3k

Countries citing papers authored by Keri Tate

Since Specialization

Citations

This map shows the geographic impact of Keri Tate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keri Tate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keri Tate more than expected).

Fields of papers citing papers by Keri Tate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keri Tate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keri Tate. The network helps show where Keri Tate may publish in the future.

Co-authorship network of co-authors of Keri Tate

This figure shows the co-authorship network connecting the top 25 collaborators of Keri Tate. A scholar is included among the top collaborators of Keri Tate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keri Tate. Keri Tate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Bertaina, Alice, Rosa Bacchetta, David C. Shyr, et al.. (2023). T-allo10 Infusion after αβ depleted-HSCT in Children and Young Adults with Hematologic Malignancies: Improved Immune Reconstitution in the Absence of Severe GvHD. Transplantation and Cellular Therapy. 29(2). S209–S210. 1 indexed citations

Sato, Yohei, Abinaya Nathan, J. Fraser Wright, et al.. (2023). A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products. Molecular Therapy — Methods & Clinical Development. 31. 101150–101150. 7 indexed citations

Narayan, Rupa, Jonathan Benjamin, Omid Shah, et al.. (2019). Donor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms. Biology of Blood and Marrow Transplantation. 25(7). 1293–1303. 17 indexed citations

Muffly, Lori, Kevin Sheehan, Randall Armstrong, et al.. (2018). Infusion of donor-derived CD8+ memory T cells for relapse following allogeneic hematopoietic cell transplantation. Blood Advances. 2(6). 681–690. 29 indexed citations

Johnston, Laura, Randall Armstrong, Jeanette Baker, et al.. (2016). A Phase I Study of Donor Regulatory T Cells As Treatment for Steroid Dependent/Refractory Chronic Graft Versus Host Disease. Blood. 128(22). 385–385. 7 indexed citations

Muffly, Lori, Kevin Sheehan, Randall Armstrong, et al.. (2016). Phase I Study of CD8 Memory T-Cell Donor Lymphocyte Infusion for Relapse of Hematologic Malignancies Following Matched Related Donor Allogeneic Hematopoietic Cell Transplantation. Blood. 128(22). 4615–4615. 1 indexed citations

Narayan, Rupa, Jonathan Benjamin, Ginna G. Laport, et al.. (2015). Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms. Blood. 126(23). 3232–3232.

Benjamin, Jonathan, Ginna G. Laport, Keri Tate, et al.. (2013). Early Infusion Of Donor-Derived CIK Cells As Consolidative Immunotherapy Following Non-Myeloablative Allogeneic Transplantation: Safety and Feasibility. Blood. 122(21). 899–899. 5 indexed citations

Gill, Saar, Jeanette Baker, Aaron T. Smith, et al.. (2012). Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. Blood. 119(24). 5758–5768. 137 indexed citations

10.

Pethig, Ronald, Catherine Carswell-Crumpton, Yan Chen, et al.. (2002). Dielectrophoretic studies of the activation of human T lymphocytes using a newly developed cell profiling system. Electrophoresis. 23(13). 2057–2057. 71 indexed citations

11.

Lee, Christopher, Michael N. Liang, Keri Tate, et al.. (1998). Evidence That the Autoimmune Antigen Myelin Basic Protein (MBP) Ac1-9 Binds Towards One End of the Major Histocompatibility Complex (MHC) Cleft. The Journal of Experimental Medicine. 187(9). 1505–1516. 41 indexed citations

12.

Rabinowitz, Joshua D., Michael N. Liang, Keri Tate, et al.. (1997). Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex. Proceedings of the National Academy of Sciences. 94(16). 8702–8707. 25 indexed citations

13.

Conboy, Irina M., Rosemarie H. DeKruyff, Keri Tate, et al.. (1997). Novel Genetic Regulation of T Helper 1 (Th1)/Th2 Cytokine Production and Encephalitogenicity in Inbred Mouse Strains. The Journal of Experimental Medicine. 185(3). 439–452. 22 indexed citations

14.

Rabinowitz, Joshua D., Craig Beeson, Christoph Wülfing, et al.. (1996). Altered T Cell Receptor Ligands Trigger a Subset of Early T Cell Signals. Immunity. 5(2). 125–135. 143 indexed citations

15.

Tate, Keri, et al.. (1995). Interactions among polymorphic and conserved residues in MHC class II proteins affect MHC-peptide conformation and T cell recognition. International Immunology. 7(5). 747–761. 21 indexed citations

16.

Paborsky, Lisa R., Karen L. Fisher, Richard M. Lawn, et al.. (1990). Mammalian cell transient expression of tissue factor for the production of antigen. Protein Engineering Design and Selection. 3(6). 547–553. 42 indexed citations

17.

Paborsky, Lisa R., Keri Tate, Reed J. Harris, et al.. (1989). Purification of recombinant human tissue factor. Biochemistry. 28(20). 8072–8077. 98 indexed citations

18.

Emorine, Laurent J., Stéfano Marullo, Gilles Patey, et al.. (1989). Molecular Characterization of the Human β ₃ -Adrenergic Receptor. Science. 245(4922). 1118–1121. 897 indexed citations breakdown →

19.

Tate, Keri, Deborah L. Higgins, William E. Holmes, et al.. (1987). Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesis. Biochemistry. 26(2). 338–343. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact